Point72 Asset Management, L.P. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Stamford, CT
SEC filing record 1 source field available
Fiscal year end
31 December
Point72 Asset Management, L.P. has filed 1,047 SEC EDGAR filings since 08 Apr 2014

SEC filing history

Showing 101-125 of 709 matching filings.

Per page
25
Current page
5
SC 13G

ITERUM THERAPEUTICS PLC

Filing date
31 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ARCUTIS BIOTHERAPEUTICS, INC.

Filing date
31 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CORBUS PHARMACEUTICALS HOLDINGS, INC.

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

FATE THERAPEUTICS INC

Filing date
25 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

C4 THERAPEUTICS, INC.

Filing date
04 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G filing

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PAGSEGURO DIGITAL LTD.

Filing date
28 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PROTAGONIST THERAPEUTICS, INC.

Filing date
18 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

AMYLYX PHARMACEUTICALS, INC.

Filing date
11 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

FARFETCH LIMITED

Filing date
01 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CELLDEX THERAPEUTICS, INC.

Filing date
20 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

LYRA THERAPEUTICS, INC.

Filing date
16 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

KORRO BIO, INC.

Filing date
09 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SYNDAX PHARMACEUTICALS INC

Filing date
31 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SEMTECH CORP

Filing date
20 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIOHAVEN LTD.

Filing date
18 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

MADISON SQUARE GARDEN ENTERTAINMENT CORP.

Filing date
10 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

RAPID7, INC.

Filing date
10 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

VISTAGEN THERAPEUTICS, INC.

Filing date
05 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TPI COMPOSITES, INC

Filing date
05 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

MORPHIC HOLDING, INC.

Filing date
02 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIONOMICS LIMITED/FI

Filing date
29 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CRINETICS PHARMACEUTICALS, INC.

Filing date
18 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CYBIN INC.

Filing date
15 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TURNSTONE BIOLOGICS CORP.

Filing date
27 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .